investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Clinical Studies to Circumvent Drug Resistance
Susan Bates
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Using bioinformatics approaches to identify mechanisms of or pathways involved in drug resistance
Related projects
Daniel M Spielman
Imaging Brain Metabolism Using MRS of Hyperpolarized 13C-Pyruvate
Brain, nervous system
Elena N Pugacheva
The Role of HEF1 Protein in Division and Invasion of Metastatic Breast Cancer
Breast
Alice Berger
Investigating the role of the small GTPase RIT1 in lung adenocarcinoma
Trachea, bronchus and lung
David FitzGerald
Bio-Therapies for the Treatment of Cancer
Trachea, bronchus and lung
Thangaiyan Rabi
Novel Oleanane Triterpenoid AMR-MeOAc for Breast Cancer Prevention and Therapy
Breast
Needs Assessment to Assess Barriers to Developing a Comprehensive Cancer Center in LMICs
Breast
Julie Secombe
Distinct Modes of Gene Regulation by KDM5
Breast
Rakesh Kumar
Pak1 Signaling and Targets in Breast Cancer Progression
Breast
Lalage Wakefield
Development of TGF-beta antagonists for cancer therapy
Breast